Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?
Heidi Chwan KoRebecca A PrevisKyle C StricklandJonathan KleinBrian CaveneyChiara ChiruzziMarcia EisenbergEric A SeversonShakti RamkissoonKamal S SainiPublished in: Oncology and therapy (2023)
Keyphrases